IL6 and systemic lupus erythematosus: Specifically, several studies have pointed to increased systemic levels of cytokines such as interleukin 6 (IL-6) and neurotoxic anti-N-methyl-d-aspartate receptor (NMDAR) antibodies in SLE patients with CD [25–27].